Zhihao Sun

Title: The Innovations of Zhihao Sun

Introduction

Zhihao Sun is a prominent inventor based in Yangzhou, China. He has made significant contributions to the field of avian influenza research. His work focuses on developing innovative vaccines to combat this serious viral threat.

Latest Patents

Zhihao Sun holds a patent for a recombinant H7N9 subtype avian influenza virus, inactivated marked vaccine, and its preparation method. This invention provides a recombinant H7N9 subtype avian influenza virus, utilizing strain JD/17 as the parent virus. The patent describes a method where a peptide sequence in the HA protein of strain JD/17 is replaced with a peptide sequence from the HA protein of H3 subtype. The strain JD/17 has a preservation number of CCTCC No. V201862. The results indicate that the rescued virus maintains similar biological characteristics to the parent virus, such as high HA titers and EID50. Chickens immunized with the marked inactivated and emulsified vaccine produce a high level of antibody, which can be distinguished from antibodies produced by naturally infected chickens.

Career Highlights

Zhihao Sun is affiliated with Yangzhou University, where he conducts his research and development work. His innovative approach to vaccine development has positioned him as a key figure in the fight against avian influenza. His dedication to advancing public health through scientific research is commendable.

Collaborations

Zhihao Sun collaborates with notable colleagues, including Daxin Peng and Sujuan Chen. Their combined expertise enhances the research efforts at Yangzhou University, contributing to the advancement of vaccine technology.

Conclusion

Zhihao Sun's contributions to the field of avian influenza research through his innovative patent demonstrate his commitment to public health. His work not only advances scientific knowledge but also provides practical solutions to combat viral threats.